However, while recent studies have provided further evidence of the tumor suppressive role of YY2 as opposed to the protooncogenic role of YY1, no studies have suggested that they could regulate common binding site in the same target gene antagonistically and exert opposite functions. The gene discussed is YY1; the disease is neoplasm.